US RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
US RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy Sept 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Chevron, Exxon Mobil and GoDaddy, on Friday.
HIGHLIGHTS
* Akamai Technologies Inc AKAM.O: JP Morgan raises target price to $167 from $158 |
* Chevron CVX.N: HSBC raises target price to $250 from $218 |
* Exxon Mobil XOM.N: HSBC raises target price to $172 from $158 |
* GoDaddy Inc GDDY.N: Jefferies raises target price to $100 from $85 |
* Zscaler Inc ZS.O: RBC raises target price to $236 from $210 |
The following is a summary of research actions on US companies reported by Reuters on Friday. Stock entries are in alphabetical order.
* 3M Company MMM.N: Bernstein raises target price to $171 from $145 |
* 3M Company MMM.N: Bernstein raises to market-perform from underperform |
* Acadia Pharmaceuticals Inc ACAD.O: BMO cuts target price to $34 from $36 |
* Acadia Pharmaceuticals Inc ACAD.O: Citigroup cuts target price to $33 from $40 |
* Acadia Pharmaceuticals Inc ACAD.O: Deutsche Bank cuts target price to $31 from $38 |
* Acadia Pharmaceuticals Inc ACAD.O: Needham cuts target price to $35 from $41 |
* Acadia Pharmaceuticals Inc ACAD.O: Oppenheimer cuts target price to $23 from $25 |
* Acadia Pharmaceuticals, Inc. ACAD.O: H.C. Wainwright cuts PT to $33 from $37 |
* Advanced Micro Devices AMD.O: BofA Global Research ups price objective to $720 from $620 |
* Akamai Technologies AKAM.O: JP Morgan raises target price to $167 from $158 |
* Akamai Technologies AKAM.O: TD Cowen raises target price to $149 from $140 |
* Akamai Technologies Inc AKAM.O: UBS raises target price to $148 from $143 |
* Almonty Industries Inc ALM.O: Stifel initiates coverage with buy rating; PT $25 |
* Ameren Corp AEE.N: RBC cuts target price to $107 from $114 |
* Andersen Group Inc ANDG.N: Truist Securities raises target price to $70 from $55 |
* Axogen Inc AXGN.O: Raymond James raises target price to $53 from $48 |
* Bank of New York Mellon Corp BNY.N: Truist Securities cuts PT to $172 from $178 |
* Billiontoone, Inc. BLLN.O: Piper Sandler raises target price to $140 from $108 |
* Biodesix, Inc. BDSX.O: H.C. Wainwright raises target price to $38 from $27 |
* Camden Property Trust CPT.N: Truist Securities cuts target price to $108 from $123 |
* Cardinal Infrastructure Group CDNL.O: Truist Securities initiates coverage with buy rating; PT $40 |
* Carmax Inc KMX.N: Stephens raises target price to $74 from $66 |
* CF Industries Holdings Inc CF.N: Bernstein initiates coverage with outperform rating; PT $162 |
* Charles River Laboratories CRL.N: Baird raises target price to $334 from $291 |
* Charles River Laboratories CRL.N: Deutsche Bank raises target price to $320 from $300 |
* Charles River Laboratories CRL.N: Mizuho raises target price to $295 from $264 |
* Charles River Laboratories CRL.N: RBC raises target price to $322 from $282 |
* Charles River Laboratories CRL.N: TD Cowen raises target price to $325 from $300 |
* Chemed Corporation CHE.N: UBS initiates coverage with buy rating and PT $650 |
* Chevron CVX.N: HSBC raises target price to $250 from $218 |
* Cinemark Holdings Inc CNK.N: Morgan Stanley cuts target price to $40 from $42 |
* Comcast Corporation CMCSA.O: Citigroup cuts target price to $27.50 from $30 |
* Comcast Corporation CMCSA.O: Keybanc cuts to underweight from sector weight |
* Comstock Resources Inc CRK.N: Jefferies initiates coverage with hold rating; PT $14 |
* Constellation Brands In STZ.N: JP Morgan cuts target price to $133 from $165 |
* Costco Wholesale Corp COST.O: Bernstein cuts target price to $1,143 from $1,144 |
* Costco Wholesale Corp COST.O: D.A. Davidson raises target price to $1040 from $1000 |
* Costco Wholesale Corp COST.O: JP Morgan cuts target price to $1015 from $1100 |
* Costco Wholesale Corp COST.O: Mizuho cuts target price to $1065 from $1100 |
* Costco Wholesale Corp COST.O: Raymond James cuts target price to $1050 from $1100 |
* Costco Wholesale Corp COST.O: Truist Securities cuts target price to $955 from $1011 |
* Cullinan Therapeutics Inc CGEM.O: H.C. Wainwright raises target price to $35 from $30 |
* Damora Therapeutics Inc (Pre-Reincorporation) DMRA.O: Guggenheim raises PT to $60 from $40 |
* Darden Restaurants Inc DRI.N: BMO cuts target price to $220 from $225 |
* Darden Restaurants Inc DRI.N: Citigroup cuts target price to $247 from $248 |
* Darden Restaurants Inc DRI.N: Mizuho raises target price to $245 from $235 |
* Dow Inc. DOW.N: UBS cuts target price to $30 from $32 |
* Emerson EMR.N: TD Cowen raises target price to $170 from $150 |
* Everpure Inc P.N: Raymond James raises target price to $140 from $122 |
* Everpure Inc P.N: Susquehanna raises target price to $175 from $145 |
* Exxon Mobil XOM.N: HSBC raises target price to $172 from $158 |
* First Financial Bancorp FFBC.O: Truist Securities raises to buy from hold; raises PT to $37 from $35 |
* First Financial Bancorp FFBC.O: Truist Securities raises to buy from hold; raises PT to $37 from $35 |
* Gen Digital Inc GEN.O: RBC cuts target price to $26 from $30 |
* GoDaddy Inc GDDY.N: Jefferies raises target price to $100 from $85 |
* Grail Inc GRAL.O: Mizuho raises target price to $100 from $65 |
* Gulfport Energy Corp GPOR.N: Jefferies cuts to hold from buy; cuts PT to $180 from $239 |
* H.B. Fuller Company FUL.N: Baird cuts target price to $65 from $75 |
* H.B. Fuller Company FUL.N: Citigroup cuts target price to $63 from $75 |
* Infleqtion Inc INFQ.N: BTIG raises target price to $25 from $22 |
* Knife River Corp KNF.N: B. Riley cuts target price to $65 from $105 |
* Lumexa Imaging Holdings LMRI.O: Keybanc initiates coverage with overweight rating; PT $18 |
* Medline Inc. MDLN.O: UBS cuts target price to $43 from $45 |
* Merlin Inc MRLN.O: Canaccord Genuity initiates coverage with buy rating; PT $7.5 |
* Meta META.O: Canaccord Genuity raises target price to $950 from $930 |
* Meta META.O: Deutsche Bank raises target price to $820 from $750 |
* Meta META.O: TD Cowen raises target price to $865 from $750 |
* Natera Inc NTRA.O: RBC raises target price to $460 from $350 |
* Nike, Inc. NKE.N: BofA Global Research cuts to underperform from neutral; cuts price objective to $30 from $47 |
* Oklo Inc. OKLO.N: UBS cuts target price to $41 from $55 |
* Okta Inc OKTA.O: BMO raises target price to $230 from $187 |
* Okta Inc OKTA.O: Citigroup raises target price to $205 from $165 |
* Okta Inc OKTA.O: Stephens raises target price to $240 from $190 |
* Okta Inc OKTA.O: Truist Securities raises target price to $235 from $200 |
* Okta, Inc. OKTA.O: Macquarie raises target price to $240 from $185 |
* Origin Bancorp Inc OBK.N: Stonex initiates coverage with hold rating |
* Paychex, Inc. PAYX.O: TD Cowen cuts target price to $105 from $117 |
* PayPal PYPL.O: Deutsche Bank cuts target price to $55 from $60 |
* PDF Solutions Inc PDFS.O: Needham initiates coverage with buy rating; PT $60 |
* Precigen Inc PGEN.O: B. Riley initiates coverage with buy rating; price target $12 |
* Restaurant Brands International Inc QSR.N: Argus Research cuts to hold from buy |
* Rezolute Inc RZLT.O: Jefferies raises target price to $7 from $6 |
* Seaport Therapeutics SPTX.O: Raymond James initiates coverage with strong buy rating; PT $46 |
* Southern Co SO.N: Citigroup cuts target price to $104 from $114 |
* Sprouts Farmers market SFM.O: Deutsche Bank cuts target price to $77 from $84 |
* Standardaero Inc SARO.N: Jefferies cuts target price to $25 from $30 |
* Surrozen Inc SRZN.O: H.C. Wainwright raises target price to $54 from $44 |
* Synopsys, Inc. SNPS.O: HSBC raises to buy rating; raises PT to $700 from $490 |
* TD Synnex Corporation SNX.N: UBS raises target price to $379 from $352 |
* Third Coast Bancshares Inc TCBX.N: Stonex initiates coverage with buy rating; PT $54 |
* Triumph Financial Inc TFIN.N: Raymond James cuts target price to $84 from $89 |
* Twilio Inc TWLO.N: HSBC cuts to reduce rating |
* Uipath Inc PATH.N: UBS cuts target price to $14 from $15 |
* Wealthfront Corp WLTH.O: Needham initiates coverage with buy rating; PT $13 |
* Westlake Corp WLK.N: UBS cuts target price to $98 from $106 |
* Zscaler Inc ZS.O: Mizuho raises target price to $220 from $210 |
* Zscaler Inc ZS.O: RBC raises target price to $236 from $210 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Recent news on Natera
See all newsBrief: FDA Grants Breakthrough Device Designation For Natera’S Multi-Cancer Early Detection Assay
Brief: Alliance Foundation Trials And Natera Announce Aft-70 Navigate A Global, Randomized, Phase Iii Trial Evaluating Genentech’S Oral Selective Estrogen Receptor Degrader With Signatera Mrd-Guided Cdk4/6 Inhibitor Therapy In Breast Cancer
US RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
Brief: Natera Says Signatera Commercial Launch In Japan Expected In 1H 2027
Brief: Natera To Support New Clinical Trial Assessing Ctdna Dynamics With Latitud In Advanced Skin Cancers